CIK: 0001816307 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 12, 2026
Total Value ($000): $720,051 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IMNM | IMMUNOME INC | 1,126,210 | $24,191 | 3.4% | $17.55 | 0.0% | COM | 45257U108 |
| — | UNIQURE NV | 720,800 | $17,249 | 2.4% | — | — | CALL | N90064901 |
| PFE | PFIZER INC | 419,134 | $10,436 | 1.4% | $25.03 | 0.0% | COM | 717081103 |
| GH | GUARDANT HEALTH INC | 91,914 | $9,388 | 1.3% | $89.46 | 0.0% | COM | 40131M109 |
| SYRE | SPYRE THERAPEUTICS INC | 187,737 | $6,150 | 0.9% | $26.13 | 0.0% | COM NEW | 00773J202 |
| SLNO | SOLENO THERAPEUTICS INC | 117,485 | $5,440 | 0.8% | $54.83 | 0.0% | COM | 834203309 |
| — | KALVISTA PHARMACEUTICALS INC | 290,600 | $4,693 | 0.7% | — | — | CALL | 483497903 |
| FULC | FULCRUM THERAPEUTICS INC | 394,650 | $4,463 | 0.6% | $10.18 | 0.0% | COM | 359616109 |
| — | FULCRUM THERAPEUTICS INC | 391,900 | $4,432 | 0.6% | — | — | CALL | 359616909 |
| SRZN | SURROZEN INC | 157,323 | $3,556 | 0.5% | $16.18 | 0.0% | COM NEW | 86889P208 |
| RLAY | RELAY THERAPEUTICS INC | 398,167 | $3,368 | 0.5% | $7.14 | 0.0% | COM | 75943R102 |
| TARS | TARSUS PHARMACEUTICALS INC | 36,124 | $2,958 | 0.4% | $74.67 | 0.0% | COM | 87650L103 |
| KYMR | KYMERA THERAPEUTICS INC | 34,589 | $2,691 | 0.4% | $67.53 | 0.0% | COM | 501575104 |
| NXTC | NEXTCURE INC | 176,057 | $2,498 | 0.3% | $10.36 | 0.0% | COM NEW | 65343E207 |
| CTMX | CYTOMX THERAPEUTICS INC | 385,974 | $1,644 | 0.2% | $3.80 | 0.0% | COM | 23284F105 |
| XFOR | X4 PHARMACEUTICALS INC | 357,387 | $1,430 | 0.2% | $3.63 | 0.0% | COM NEW | 98420X202 |
| EWTX | EDGEWISE THERAPEUTICS INC | 42,052 | $1,044 | 0.1% | $20.07 | 0.0% | COM | 28036F105 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 100,000 | $750 | 0.1% | $10.14 | 0.0% | COM | 35104E100 |
| ADGM | ADAGIO MED HLDGS INC | 515,384 | $536 | 0.1% | $1.19 | 0.0% | COM | 00534B100 |
| PALI | PALISADE BIO INC | 102,108 | $240 | 0.0% | $1.92 | 0.0% | COM | 696389402 |
| IBIO | IBIO INC | 106,000 | $205 | 0.0% | $1.36 | 0.0% | COM NEW | 451033708 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CELC | CELCUITY INC | 375,132 (+323.0%) | $37,416 (+754.0%) | 5.2% | $72.23 | +13.8% | COM | 15102K100 |
| COGT | COGENT BIOSCIENCES INC | 1,245,254 (+52.8%) | $44,231 (+277.9%) | 6.1% | $17.47 | +61.0% | COM | 19240Q201 |
| KALV | KALVISTA PHARMACEUTICALS INC | 2,427,118 (+78.0%) | $39,198 (+136.0%) | 5.4% | $11.97 | +10.7% | COM | 483497103 |
| PRAX | PRAXIS PRECISION MEDICINES I | 82,465 (+61.0%) | $24,306 (+795.5%) | 3.4% | $100.25 | +85.8% | COM NEW | 74006W207 |
| KOD | KODIAK SCIENCES INC | 1,023,122 (+2.3%) | $28,606 (+74.7%) | 4.0% | $7.38 | +177.6% | COM | 50015M109 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 1,029,066 (+48.1%) | $16,136 (+213.3%) | 2.2% | $7.95 | +69.5% | COM | 61225M102 |
| URGN | UROGEN PHARMA LTD | 1,738,821 (+10.2%) | $40,723 (+29.4%) | 5.7% | $13.27 | +63.5% | COM | M96088105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 458,203 (+224.4%) | $11,460 (+234.6%) | 1.6% | $24.69 | — | SPONSORED ADS | 152309100 |
| VCYT | VERACYTE INC | 357,558 (+51.6%) | $15,053 (+86.0%) | 2.1% | $34.23 | +17.7% | COM | 92337F107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 642,899 (+38.6%) | $13,507 (+89.3%) | 1.9% | $17.40 | +0.2% | COM | 87164F105 |
| BNTC | BENITEC BIOPHARMA INC | 731,717 (+164.9%) | $9,856 (+154.3%) | 1.4% | $13.20 | +4.7% | COM NEW | 08205P209 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 348,569 (+34.3%) | $10,847 (+93.7%) | 1.5% | $20.44 | +34.2% | COM | 92790C104 |
| DNTH | DIANTHUS THERAPEUTICS INC | 750,136 (+11.1%) | $30,913 (+16.4%) | 4.3% | $26.43 | +46.7% | COM | 252828108 |
| CTNM | CONTINEUM THERAPEUTICS INC | 307,540 (+85.1%) | $3,515 (+80.0%) | 0.5% | $9.60 | +18.8% | CL A | 21217B100 |
| CERS | CERUS CORP | 2,814,383 (+3.6%) | $5,798 (+34.3%) | 0.8% | $3.26 | -46.9% | COM | 157085101 |
| CGEN | COMPUGEN LTD | 3,479,805 (+5.1%) | $5,324 (+9.4%) | 0.7% | $1.61 | +3.4% | ORD | M25722105 |
| MLYS | MINERALYS THERAPEUTICS INC | 94,983 (+18.7%) | $3,447 (+13.6%) | 0.5% | $16.01 | +150.4% | COM | 603170101 |
| CCCC | C4 THERAPEUTICS INC | 1,994,224 (+5.1%) | $3,809 (-9.6%) | 0.5% | $2.40 | -1.3% | COM STK | 12529R107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RNA | AVIDITY BIOSCIENCES INC | 844,633 | $36,801 | 5.1% | $30.30 | +113.2% | — | 05370A108 |
| — | AKERO THERAPEUTICS INC | 643,636 | $30,560 | 4.2% | $24.40 | — | — | 00973Y108 |
| — | UNITED THERAPEUTICS CORP DEL | 59,900 | $25,111 | 3.5% | — | — | PUT | 91307C952 |
| — | CIDARA THERAPEUTICS INC | 220,902 | $21,154 | 2.9% | $73.62 | — | — | 171757206 |
| CYTK | CYTOKINETICS INC | 211,000 | $11,597 | 1.6% | $41.20 | +51.0% | — | 23282W605 |
| VSTM | VERASTEM INC | 1,042,757 | $9,208 | 1.3% | $7.44 | +19.8% | — | 92337C203 |
| SRRK | SCHOLAR ROCK HLDG CORP | 233,920 | $8,711 | 1.2% | $31.39 | +19.5% | — | 80706P103 |
| ALKS | ALKERMES PLC | 180,513 | $5,415 | 0.8% | $28.20 | +6.2% | — | G01767105 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 457,414 | $5,297 | 0.7% | $11.58 | — | — | 107924102 |
| — | COGENT BIOSCIENCES INC | 360,000 | $5,170 | 0.7% | — | — | CALL | 19240Q901 |
| PHVS | PHARVARIS N V | 183,903 | $4,588 | 0.6% | $22.18 | +8.6% | — | N69605108 |
| BCAX | BICARA THERAPEUTICS INC | 250,606 | $3,957 | 0.5% | $11.19 | +52.6% | — | 055477103 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 88,910 | $3,452 | 0.5% | $22.32 | +79.7% | — | G52694109 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 230,837 | $3,287 | 0.5% | $11.51 | +23.1% | — | 30233G209 |
| ZURA | ZURA BIO LTD | 720,452 | $3,120 | 0.4% | $1.80 | +119.9% | — | G9TY5A101 |
| DCTH | DELCATH SYS INC | 203,386 | $2,186 | 0.3% | $11.20 | -11.3% | — | 24661P807 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 50,000 | $2,083 | 0.3% | $31.97 | +39.2% | — | 22663K107 |
| CAMP | CAMP4 THERAPEUTICS CORP | 653,594 | $1,961 | 0.3% | $1.85 | +129.7% | — | 13463J101 |
| DYN | DYNE THERAPEUTICS INC | 100,000 | $1,265 | 0.2% | $11.41 | +66.0% | — | 26818M108 |
| LBRX | LB PHARMACEUTICALS INC | 70,000 | $1,105 | 0.2% | $15.87 | +10.1% | — | 50180M108 |
| — | CAPRICOR THERAPEUTICS INC | 144,700 | $1,043 | 0.1% | — | — | PUT | 14070B959 |
| — | MERSANA THERAPEUTICS INC | 133,636 | $1,037 | 0.1% | $7.76 | — | — | 59045L205 |
| — | ATYR PHARMA INC | 1,250,000 | $901 | 0.1% | — | — | PUT | 002120952 |
| IMVT | IMMUNOVANT INC | 50,000 | $806 | 0.1% | $16.19 | +37.7% | — | 45258J102 |
| — | ARCTURUS THERAPEUTICS HLDGS | 42,000 | $774 | 0.1% | — | — | PUT | 03969T959 |
| — | SYNDAX PHARMACEUTICALS INC | 50,000 | $770 | 0.1% | — | — | CALL | 87164F905 |
| — | ULTRAGENYX PHARMACEUTICAL IN | 25,000 | $752 | 0.1% | — | — | PUT | 90400D958 |
| — | MOONLAKE IMMUNOTHERAPEUTICS | 65,000 | $466 | 0.1% | — | — | CALL | 61559X904 |
| MODD | MODULAR MED INC | 639,531 | $448 | 0.1% | $1.79 | -72.7% | — | 60785L207 |
| BDSX | BIODESIX INC | 49,607 | $375 | 0.1% | $7.69 | -4.3% | — | 09075X207 |
| MBX | MBX BIOSCIENCES INC | 15,000 | $263 | 0.0% | $13.37 | +81.5% | — | 55287L101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 10,675 | $219 | 0.0% | $19.01 | +4.8% | — | 29337E102 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 30,000 | $215 | 0.0% | $40.73 | -71.0% | — | 61559X104 |
| ARCT | ARCTURUS THERAPEUTICS HLDGS | 3,445 | $63 | 0.0% | $16.06 | -32.8% | — | 03969T109 |
| NKTR | NEKTAR THERAPEUTICS | 365 | $21 | 0.0% | $12.37 | +352.3% | — | 640268306 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| QURE | UNIQURE NV | 126,047 (-72.3%) | $3,016 (-88.6%) | 0.4% | $15.14 | +154.9% | SHS | N90064101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 135,950 (-63.3%) | $14,552 (-61.1%) | 2.0% | $39.46 | +168.8% | COM | 76243J105 |
| INSM | INSMED INC | 71,256 (-65.5%) | $12,401 (-58.3%) | 1.7% | $56.86 | +220.9% | COM PAR $.01 | 457669307 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,116,604 (-42.7%) | $9,134 (-60.9%) | 1.3% | $6.76 | +70.4% | COM | 68622P109 |
| — | ULTRAGENYX PHARMACEUTICAL IN | 110,000 (-79.2%) | $2,530 (-84.1%) | 0.4% | — | — | CALL | 90400D908 |
| ABVX | ABIVAX SA | 422,193 (-21.8%) | $56,935 (+24.3%) | 7.9% | $84.90 | — | SPONSORED ADS | 00370M103 |
| CGON | CG ONCOLOGY INC | 361,158 (-43.4%) | $14,995 (-41.7%) | 2.1% | $24.86 | +66.5% | COM | 156944100 |
| GOSS | GOSSAMER BIO INC | 2,135,722 (-55.3%) | $6,621 (-47.3%) | 0.9% | $1.12 | +154.0% | COM | 38341P102 |
| RAPP | RAPPORT THERAPEUTICS INC | 9,659 (-95.3%) | $293 (-95.2%) | 0.0% | $17.84 | +55.1% | COM | 75383L102 |
| GUTS | FRACTYL HEALTH INC | 9,840,041 (-7.2%) | $21,648 (+28.4%) | 3.0% | $1.40 | +15.4% | COM | 35168W103 |
| PCVX | VAXCYTE INC | 148,787 (-52.7%) | $6,865 (-39.4%) | 1.0% | $32.81 | +36.3% | COM | 92243G108 |
| CMPX | COMPASS THERAPEUTICS INC | 1,051,343 (-62.9%) | $5,646 (-43.1%) | 0.8% | $2.86 | +61.5% | COM | 20454B104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 206,280 (-77.9%) | $5,157 (-43.6%) | 0.7% | $6.00 | +196.3% | COM | 68062P106 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 191,074 (-45.2%) | $5,190 (-42.5%) | 0.7% | $27.17 | -3.1% | COM NEW | 15117B202 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 506,242 (-27.7%) | $6,115 (-35.7%) | 0.8% | $9.41 | +44.3% | COM | 03237H101 |
| BIIB | BIOGEN INC | 75,412 (-6.2%) | $13,272 (+17.8%) | 1.8% | $135.17 | +20.9% | COM | 09062X103 |
| ABEO | ABEONA THERAPEUTICS INC | 627,738 (-36.9%) | $3,308 (-37.0%) | 0.5% | $5.74 | -12.3% | COM NEW | 00289Y206 |
| ERAS | ERASCA INC | 1,317,584 (-3.7%) | $4,901 (+64.3%) | 0.7% | $2.20 | +27.8% | COM | 29479A108 |
| SION | SIONNA THERAPEUTICS INC | 41,460 (-61.9%) | $1,706 (-46.7%) | 0.2% | $15.09 | +151.3% | COM | 829401108 |
| TRVI | TREVI THERAPEUTICS INC | 541,240 (-8.1%) | $6,776 (+25.8%) | 0.9% | $3.55 | +225.4% | COM | 89532M101 |
| TELA | TELA BIO INC | 2,647,512 (-4.9%) | $3,124 (-24.7%) | 0.4% | $4.46 | -71.6% | COM | 872381108 |
| LXEO | LEXEO THERAPEUTICS INC | 617,608 (-20.7%) | $6,133 (+18.6%) | 0.9% | $4.84 | +88.7% | COM | 52886X107 |
| NUVL | NUVALENT INC | 311,430 (-16.3%) | $31,327 (-2.7%) | 4.4% | $73.68 | +33.8% | COM | 670703107 |
| ELUT | ELUTIA INC | 2,751,314 (-3.5%) | $1,906 (-24.9%) | 0.3% | $3.14 | -75.8% | CL A COM | 05479K106 |
| AVTX | AVALO THERAPEUTICS INC | 524,436 (-27.3%) | $9,524 (+3.9%) | 1.3% | $8.60 | +96.3% | COM NEW | 05338F306 |
| ASND | ASCENDIS PHARMA A/S | 49,228 (-8.1%) | $10,497 (-1.4%) | 1.5% | $147.80 | — | SPONSORED ADR | 04351P101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AARD | AARDVARK THERAPEUTICS INC | 303,939 | $3,989 | 0.6% | $10.73 | +16.3% | COM | 002942100 |
| RADX | RADIOPHARM THERANOSTICS LTD | 187,406 | $978 | 0.1% | $4.49 | — | SPONSORED ADS | 75041J101 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 104,828 | $3 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |